Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
It may be the preferred choice for patients with established CV disease
SURMOUNT-4 showed that patients who lost weight on tirzepatide during a 36-week lead-in and then continued the drug maintained a further 5.5% reduction, while those switched to placebo regained 14.8% [13]
Aim for an area at least two inches away from your belly button to avoid sensitive tissue
Elderly patients and other special populations Older adults ( 65 years) with MASLD may experience greater gastrointestinal intolerance and dehydration risk
US$ 26.68
US$ 28.64
US$ 27.22
US$ 27.73
US$ 24.48
